Vaxart Inc (VXRT)

[YJ4LIFE]

September 16, 2020
The Path to A Vaccine

By Emily Payne

The efforts are part of Operation Warp Speed (OWS), a directive to deliver 300 million doses of a safe, effective vaccine by January 2021.
Headed by the Department of Health and Human Services (HHS), OWS has partnered with private companies and other federal agencies to invest in the development, clinical testing, manufacturing and distribution of promising COVID-19 vaccine candidates.
As one of three HHS-designated Centers for Innovation in Advanced Development and Manufacturing, Emergent BioSolutions has partnered with Johnson & Johnson, AstraZeneca, Novavax and Vaxart to scale up and manufacture their vaccines. These centers were established in 2012 by HHS to develop and manufacture medical countermeasures in the face of public health emergencies.
As the number of confirmed COVID-19 cases continues to climb both in the United States and worldwide, there’s no doubt that creating a vaccine is imperative.